Clinical Utility of the Modified Segmental Boost Technique for Treatment of the Pelvis and Inguinal Nodes

M. S. Moran, W. A. Castrucci, M. Ahmad, H. Song, M. W. Lund, Sridhar Mani, Daniel Chamberlain, S. A. Higgins

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: Low-lying pelvic malignancies often require simultaneous radiation to pelvis and inguinal nodes. We previously reported improved homogeneity with the modified segmental boost technique (MSBT) compared to that with traditional methods, using phantom models. Here we report our institutional clinical experience with MSBT. Methods and Materials: MSBT patients from May 2001 to March 2007 were evaluated. Parameters analyzed included isocenter/multileaf collimation shifts, time per fraction (four fields), monitor units (MU)/fraction, femoral doses, maximal dose relative to body mass index, and inguinal node depth. In addition, a dosimetric comparison of the MSBT versus intensity modulated radiation therapy (IMRT) was conducted. Results: Of the 37 MSBT patients identified, 32 were evaluable. Port film adjustments were required in 6% of films. Median values for each analyzed parameter were as follows: MU/fraction, 298 (range, 226-348); delivery time, 4 minutes; inguinal depth, 4.5 cm; volume receiving 45 Gy (V45), 7%; V27.5, 87%; body mass index, 25 (range, 16.0-33.8). Inguinal dose was 100% in all cases; in-field inhomogeneity ranged from 111% to 118%. IMRT resulted in significantly decreased dose to normal tissue but required more time for treatment planning and a higher number of MUs (1,184 vs. 313 MU). Conclusions: In our clinical experience, the mono-isocentric MSBT provides a high degree of accuracy, improved homogeneity compared with traditional techniques, ease of simulation, treatment planning, treatment delivery, and acceptable femoral doses for pelvic/inguinal radiation fields requiring 45 to 50.4 Gy. In addition, the MSBT delivers a relatively uniform dose distribution throughout the treatment volume, despite varying body habitus. Clinical scenarios for the use of MSBT vs. intensity-modulated radiation therapy are discussed. To our knowledge, this is the first study reporting the utility of MSBT in the clinical setting.

Original languageEnglish (US)
Pages (from-to)1026-1036
Number of pages11
JournalInternational Journal of Radiation Oncology Biology Physics
Volume76
Issue number4
DOIs
StatePublished - Mar 15 2010
Externally publishedYes

Fingerprint

pelvis
Groin
acceleration (physics)
Pelvis
Radiotherapy
dosage
Thigh
Body Mass Index
monitors
radiation therapy
Radiation
Therapeutics
homogeneity
planning
delivery
collimation
radiation distribution
inhomogeneity
Neoplasms
adjusting

Keywords

  • Anal cancer
  • Inguinal radiation
  • Modified segmental boost technique
  • Pelvic intensity-modulated radiation therapy
  • Vulvar cancer

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Clinical Utility of the Modified Segmental Boost Technique for Treatment of the Pelvis and Inguinal Nodes. / Moran, M. S.; Castrucci, W. A.; Ahmad, M.; Song, H.; Lund, M. W.; Mani, Sridhar; Chamberlain, Daniel; Higgins, S. A.

In: International Journal of Radiation Oncology Biology Physics, Vol. 76, No. 4, 15.03.2010, p. 1026-1036.

Research output: Contribution to journalArticle

Moran, M. S. ; Castrucci, W. A. ; Ahmad, M. ; Song, H. ; Lund, M. W. ; Mani, Sridhar ; Chamberlain, Daniel ; Higgins, S. A. / Clinical Utility of the Modified Segmental Boost Technique for Treatment of the Pelvis and Inguinal Nodes. In: International Journal of Radiation Oncology Biology Physics. 2010 ; Vol. 76, No. 4. pp. 1026-1036.
@article{5edb2abea0fc4087b07562933b874261,
title = "Clinical Utility of the Modified Segmental Boost Technique for Treatment of the Pelvis and Inguinal Nodes",
abstract = "Purpose: Low-lying pelvic malignancies often require simultaneous radiation to pelvis and inguinal nodes. We previously reported improved homogeneity with the modified segmental boost technique (MSBT) compared to that with traditional methods, using phantom models. Here we report our institutional clinical experience with MSBT. Methods and Materials: MSBT patients from May 2001 to March 2007 were evaluated. Parameters analyzed included isocenter/multileaf collimation shifts, time per fraction (four fields), monitor units (MU)/fraction, femoral doses, maximal dose relative to body mass index, and inguinal node depth. In addition, a dosimetric comparison of the MSBT versus intensity modulated radiation therapy (IMRT) was conducted. Results: Of the 37 MSBT patients identified, 32 were evaluable. Port film adjustments were required in 6{\%} of films. Median values for each analyzed parameter were as follows: MU/fraction, 298 (range, 226-348); delivery time, 4 minutes; inguinal depth, 4.5 cm; volume receiving 45 Gy (V45), 7{\%}; V27.5, 87{\%}; body mass index, 25 (range, 16.0-33.8). Inguinal dose was 100{\%} in all cases; in-field inhomogeneity ranged from 111{\%} to 118{\%}. IMRT resulted in significantly decreased dose to normal tissue but required more time for treatment planning and a higher number of MUs (1,184 vs. 313 MU). Conclusions: In our clinical experience, the mono-isocentric MSBT provides a high degree of accuracy, improved homogeneity compared with traditional techniques, ease of simulation, treatment planning, treatment delivery, and acceptable femoral doses for pelvic/inguinal radiation fields requiring 45 to 50.4 Gy. In addition, the MSBT delivers a relatively uniform dose distribution throughout the treatment volume, despite varying body habitus. Clinical scenarios for the use of MSBT vs. intensity-modulated radiation therapy are discussed. To our knowledge, this is the first study reporting the utility of MSBT in the clinical setting.",
keywords = "Anal cancer, Inguinal radiation, Modified segmental boost technique, Pelvic intensity-modulated radiation therapy, Vulvar cancer",
author = "Moran, {M. S.} and Castrucci, {W. A.} and M. Ahmad and H. Song and Lund, {M. W.} and Sridhar Mani and Daniel Chamberlain and Higgins, {S. A.}",
year = "2010",
month = "3",
day = "15",
doi = "10.1016/j.ijrobp.2009.02.066",
language = "English (US)",
volume = "76",
pages = "1026--1036",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Clinical Utility of the Modified Segmental Boost Technique for Treatment of the Pelvis and Inguinal Nodes

AU - Moran, M. S.

AU - Castrucci, W. A.

AU - Ahmad, M.

AU - Song, H.

AU - Lund, M. W.

AU - Mani, Sridhar

AU - Chamberlain, Daniel

AU - Higgins, S. A.

PY - 2010/3/15

Y1 - 2010/3/15

N2 - Purpose: Low-lying pelvic malignancies often require simultaneous radiation to pelvis and inguinal nodes. We previously reported improved homogeneity with the modified segmental boost technique (MSBT) compared to that with traditional methods, using phantom models. Here we report our institutional clinical experience with MSBT. Methods and Materials: MSBT patients from May 2001 to March 2007 were evaluated. Parameters analyzed included isocenter/multileaf collimation shifts, time per fraction (four fields), monitor units (MU)/fraction, femoral doses, maximal dose relative to body mass index, and inguinal node depth. In addition, a dosimetric comparison of the MSBT versus intensity modulated radiation therapy (IMRT) was conducted. Results: Of the 37 MSBT patients identified, 32 were evaluable. Port film adjustments were required in 6% of films. Median values for each analyzed parameter were as follows: MU/fraction, 298 (range, 226-348); delivery time, 4 minutes; inguinal depth, 4.5 cm; volume receiving 45 Gy (V45), 7%; V27.5, 87%; body mass index, 25 (range, 16.0-33.8). Inguinal dose was 100% in all cases; in-field inhomogeneity ranged from 111% to 118%. IMRT resulted in significantly decreased dose to normal tissue but required more time for treatment planning and a higher number of MUs (1,184 vs. 313 MU). Conclusions: In our clinical experience, the mono-isocentric MSBT provides a high degree of accuracy, improved homogeneity compared with traditional techniques, ease of simulation, treatment planning, treatment delivery, and acceptable femoral doses for pelvic/inguinal radiation fields requiring 45 to 50.4 Gy. In addition, the MSBT delivers a relatively uniform dose distribution throughout the treatment volume, despite varying body habitus. Clinical scenarios for the use of MSBT vs. intensity-modulated radiation therapy are discussed. To our knowledge, this is the first study reporting the utility of MSBT in the clinical setting.

AB - Purpose: Low-lying pelvic malignancies often require simultaneous radiation to pelvis and inguinal nodes. We previously reported improved homogeneity with the modified segmental boost technique (MSBT) compared to that with traditional methods, using phantom models. Here we report our institutional clinical experience with MSBT. Methods and Materials: MSBT patients from May 2001 to March 2007 were evaluated. Parameters analyzed included isocenter/multileaf collimation shifts, time per fraction (four fields), monitor units (MU)/fraction, femoral doses, maximal dose relative to body mass index, and inguinal node depth. In addition, a dosimetric comparison of the MSBT versus intensity modulated radiation therapy (IMRT) was conducted. Results: Of the 37 MSBT patients identified, 32 were evaluable. Port film adjustments were required in 6% of films. Median values for each analyzed parameter were as follows: MU/fraction, 298 (range, 226-348); delivery time, 4 minutes; inguinal depth, 4.5 cm; volume receiving 45 Gy (V45), 7%; V27.5, 87%; body mass index, 25 (range, 16.0-33.8). Inguinal dose was 100% in all cases; in-field inhomogeneity ranged from 111% to 118%. IMRT resulted in significantly decreased dose to normal tissue but required more time for treatment planning and a higher number of MUs (1,184 vs. 313 MU). Conclusions: In our clinical experience, the mono-isocentric MSBT provides a high degree of accuracy, improved homogeneity compared with traditional techniques, ease of simulation, treatment planning, treatment delivery, and acceptable femoral doses for pelvic/inguinal radiation fields requiring 45 to 50.4 Gy. In addition, the MSBT delivers a relatively uniform dose distribution throughout the treatment volume, despite varying body habitus. Clinical scenarios for the use of MSBT vs. intensity-modulated radiation therapy are discussed. To our knowledge, this is the first study reporting the utility of MSBT in the clinical setting.

KW - Anal cancer

KW - Inguinal radiation

KW - Modified segmental boost technique

KW - Pelvic intensity-modulated radiation therapy

KW - Vulvar cancer

UR - http://www.scopus.com/inward/record.url?scp=77449100466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449100466&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2009.02.066

DO - 10.1016/j.ijrobp.2009.02.066

M3 - Article

C2 - 19596174

AN - SCOPUS:77449100466

VL - 76

SP - 1026

EP - 1036

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -